Novo Nordisk Sogroya Gains Positive CHMP Opinion in Europe
Bagsværd, Denmark, September 18, 2026 Novo Nordisk has announced that the Committee for Medicinal Products for Human Use (CHMP)...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Bagsværd, Denmark, September 18, 2026 Novo Nordisk has announced that the Committee for Medicinal Products for Human Use (CHMP)...
Basel, Switzerland, September 18, 2026 Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human...
Boston, Massachusetts, U.S., September 18, 2026 ZBeats, a digital health and medical technology company focused on cardiac diagnostics, has...
VANCOUVER, British Columbia, May 29, 2026 Optimi Health Corp. has welcomed new recommendations issued by Australia’s Therapeutic Goods Administration...
MONTREAL, Canada, May 29, 2026 Leica Biosystems, a global leader in anatomic and digital pathology solutions, and CellCarta, a...
CHICAGO, Ill., May 29, 2026 Cardiosense has achieved a major regulatory milestone with the U.S. Food and Drug Administration...
CHICAGO, IL – November 11, 2025 — Scientists at Northwestern University Feinberg School of Medicine have developed a novel...
